I-PAS Goggles for Concussion Diagnosis
Trial Summary
What is the purpose of this trial?
This trial tests if the I-PAS goggle system can reliably diagnose mild brain injuries in urgent care or emergency settings.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the I-PAS Goggles treatment for concussion diagnosis?
Research suggests that vision-based assessments, like those used in the I-PAS Goggles, can help detect subtle changes in brain function after a concussion. Tests involving eye movements and visual performance, such as eye tracking, have shown promise in improving the accuracy of concussion diagnosis.12345
How is the I-PAS Goggles treatment unique for diagnosing concussions?
The I-PAS Goggles treatment is unique because it uses vision and eye movement tests to detect concussions, focusing on how the brain controls eye movements, which is often affected by head injuries. This approach is different from other methods that may not emphasize the visual system as much, making it a novel tool for identifying and monitoring concussion symptoms.13467
Research Team
Michael E Hoffer, MD
Principal Investigator
University of Miami
Eligibility Criteria
This trial is for adults aged 18-50 who've had a head impact and are diagnosed with mild traumatic brain injury (mTBI) or concussion at specific hospitals. It's also for similar adults without head injuries as controls. Excluded are those with severe injuries, past significant head trauma, certain medical conditions, or inability to consent.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Testing
Participants undergo testing with the I-PAS Goggles to diagnose mTBI or assess minor injuries
Follow-up
Participants are monitored for recovery and readiness to return to normal activity after a head injury
Treatment Details
Interventions
- I-PAS Goggles (Diagnostic Device)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
Sylvia Daunert
University of Miami
Chief Executive Officer since 2011
PhD in Biochemistry and Molecular Biology, University of Kentucky
Bahar Motlagh
University of Miami
Chief Medical Officer since 2021
PhD in Biomedical Engineering, Ecole Polytechnique Montreal
Neurolign
Industry Sponsor